Qc Technologies Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Qc Technologies Inc 's ROA in the second quarter of 2026?
Qc Technologies Inc recorded a cumulative net loss of $-17 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -47.48%.

However, within the Healthcare sector 550 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3726, from total ROA ranking in the first quarter of 2026 at 4462.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	33.32 %	103.89 %	106.65 %	65.15 %	-31.07 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-17	-12	-12	-8	-7
Return On Assets (TTM)	-47.48 %	-35.1 %	-40.68 %	-33.5 %	-35.28 %
QCLS's Total Ranking	# 3726	# 4462	# 3815	# 3851	# 4312
Total Assets (TTM) in million	23	38	41	37	17
Seq. Total Assets Change	-40.28 %	-6.98 %	10.57 %	117.08 %	-8.68 %
Seq. Net Income Change	-	-	-	-	-

QCLS's 5 Years Annual ROA >> Back to QCLS Management Effectiveness >> Compare QCLS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 9
Sector	# 551
Overall	# 3866

Return On Assets Statistics
High	Average	Low
79.61 %	-57.96 %	-121.04 %
(Dec 31 2017)		(Sep 30 2021)

Financial Statements
Qc Technologies Inc 's Assets	$ 23 million	QCLS's Balance sheet
Qc Technologies Inc 's Income	$ -7 million	Quarterly QCLS's Income Statement
QCLS's Income by Division		See QCLS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	106.65 %	5.88 %	2.25 %	-25.84 %	-38.57 %
Total Assets in million	41	20	19	18	25
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-12	-23	-4	-15	-30
Annual Return On Assets	-28.24 %	-117.26 %	-21.26 %	-82.59 %	-120.46 %

QCLS's 5 Years Annual ROA >> Back to QCLS Management Effectiveness >> Compare QCLS ROA to its Competitors

More Return On Assets Ratios
QCLS's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QCLS's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QCLS's Competitors
Subscribers only: Roa for Qc Technologies Inc 's Suppliers
Subscribers only: Return On Assets for QCLS's Customers

You may also want to know
QCLS's Roi	QCLS's Inventory Turnover Ratio	QCLS's Growth Rates	QCLS's Dividend Comparisons
	QCLS's Profitability Ratios	QCLS's Asset Turnover Ratio	QCLS's Dividend Growth
QCLS's Roe	QCLS's Valuation Ratios	QCLS's Financial Strength Ratios	QCLS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-04T07:58:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.